| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.032 | 0.5 |